Intracavitary treatment of malignant pleural and peritoneal effusions in cancer patients.
Authors present a review of the intracavitary treatment of malignant effusions in cancer patients, experience with tetracycline, mechloretamine, quinacrine, radio-isotopes, interferon beta and interferon alpha are reviewed. Personal experience with interferon alpha is reported.
Gebbia
N
N
Chair of Chemotherapy, University of Palermo, Italy.
Mannino
R
R
Di Dino
A
A
Maxhouni
L
L
Bellone
N
N
Cinque
L
L
Liuzza
A
A
La Motta
P
P
Cannata
G
G
Gulotta
G
G
D001202:Ascitic Fluid / Q000628:therapy*; D001761:Bleomycin / Q000627:therapeutic use; D006801:Humans; D000077190:Interferon alpha-2; D016898:Interferon-alpha / Q000627:therapeutic use; D016899:Interferon-beta / Q000627:therapeutic use; D008466:Mechlorethamine / Q000627:therapeutic use; D009369:Neoplasms / Q000503:physiopathology* / Q000628:therapy; D010996:Pleural Effusion / Q000628:therapy*; D011796:Quinacrine / Q000627:therapeutic use; D011994:Recombinant Proteins; D013752:Tetracycline / Q000627:therapeutic use
D000077190:Interferon alpha-2; D016898:Interferon-alpha; D011994:Recombinant Proteins; D001761:Bleomycin; D008466:Mechlorethamine; D016899:Interferon-beta; D013752:Tetracycline; D011796:Quinacrine